293 related articles for article (PubMed ID: 11907705)
1. A potent 1,4-dihydropyridine L-type calcium channel blocker, benidipine, promotes osteoblast differentiation.
Nishiya Y; Kosaka N; Uchii M; Sugimoto S
Calcif Tissue Int; 2002 Jan; 70(1):30-9. PubMed ID: 11907705
[TBL] [Abstract][Full Text] [Related]
2. Blockade of T-type voltage-dependent Ca2+ channels by benidipine, a dihydropyridine calcium channel blocker, inhibits aldosterone production in human adrenocortical cell line NCI-H295R.
Akizuki O; Inayoshi A; Kitayama T; Yao K; Shirakura S; Sasaki K; Kusaka H; Matsubara M
Eur J Pharmacol; 2008 Apr; 584(2-3):424-34. PubMed ID: 18331727
[TBL] [Abstract][Full Text] [Related]
3. Effects of various antihypertensive drugs on the function of osteoblast.
Nishiya Y; Sugimoto S
Biol Pharm Bull; 2001 Jun; 24(6):628-33. PubMed ID: 11411549
[TBL] [Abstract][Full Text] [Related]
4. Potentiation by stannous chloride of calcium entry into osteoblastic MC3T3-E1 cells through voltage-dependent L-type calcium channels.
Hattori T; Maehashi H; Miyazawa T; Naito M
Cell Calcium; 2001 Jul; 30(1):67-72. PubMed ID: 11396989
[TBL] [Abstract][Full Text] [Related]
5. Effects of the 1, 4-dihydropyridine L-type calcium channel blocker benidipine on bone marrow stromal cells.
Ma ZP; Liao JC; Zhao C; Cai DZ
Cell Tissue Res; 2015 Aug; 361(2):467-76. PubMed ID: 25743688
[TBL] [Abstract][Full Text] [Related]
6. Involvement of calcium-sensing receptor in osteoblastic differentiation of mouse MC3T3-E1 cells.
Yamauchi M; Yamaguchi T; Kaji H; Sugimoto T; Chihara K
Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E608-16. PubMed ID: 15547142
[TBL] [Abstract][Full Text] [Related]
7. Zinc deprivation inhibits extracellular matrix calcification through decreased synthesis of matrix proteins in osteoblasts.
Alcantara EH; Lomeda RA; Feldmann J; Nixon GF; Beattie JH; Kwun IS
Mol Nutr Food Res; 2011 Oct; 55(10):1552-60. PubMed ID: 21656670
[TBL] [Abstract][Full Text] [Related]
8. Competitive and cooperative effects of Bay K8644 on the L-type calcium channel current inhibition by calcium channel antagonists.
Zahradníková A; Minarovic I; Zahradník I
J Pharmacol Exp Ther; 2007 Aug; 322(2):638-45. PubMed ID: 17475903
[TBL] [Abstract][Full Text] [Related]
9. Transglutaminase activity regulates osteoblast differentiation and matrix mineralization in MC3T3-E1 osteoblast cultures.
Al-Jallad HF; Nakano Y; Chen JL; McMillan E; Lefebvre C; Kaartinen MT
Matrix Biol; 2006 Apr; 25(3):135-48. PubMed ID: 16469487
[TBL] [Abstract][Full Text] [Related]
10. Both direct and collagen-mediated signals are required for active vitamin D3-elicited differentiation of human osteoblastic cells: roles of osterix, an osteoblast-related transcription factor.
Maehata Y; Takamizawa S; Ozawa S; Kato Y; Sato S; Kubota E; Hata R
Matrix Biol; 2006 Jan; 25(1):47-58. PubMed ID: 16266799
[TBL] [Abstract][Full Text] [Related]
11. Benidipine, an anti-hypertensive drug, inhibits reactive oxygen species production in polymorphonuclear leukocytes and oxidative stress in salt-loaded stroke-prone spontaneously hypertensive rats.
Matsubara M; Akizuki O; Ikeda J; Saeki K; Yao K; Sasaki K
Eur J Pharmacol; 2008 Feb; 580(1-2):201-13. PubMed ID: 18048030
[TBL] [Abstract][Full Text] [Related]
12. beta-cryptoxanthin stimulates cell differentiation and mineralization in osteoblastic MC3T3-E1 cells.
Uchiyama S; Yamaguchi M
J Cell Biochem; 2005 Aug; 95(6):1224-34. PubMed ID: 15962303
[TBL] [Abstract][Full Text] [Related]
13. Methotrexate (MTX) inhibits osteoblastic differentiation in vitro: possible mechanism of MTX osteopathy.
Uehara R; Suzuki Y; Ichikawa Y
J Rheumatol; 2001 Feb; 28(2):251-6. PubMed ID: 11246658
[TBL] [Abstract][Full Text] [Related]
14. Relationship between collagen synthesis and expression of the osteoblast phenotype in MC3T3-E1 cells.
Franceschi RT; Iyer BS
J Bone Miner Res; 1992 Feb; 7(2):235-46. PubMed ID: 1373931
[TBL] [Abstract][Full Text] [Related]
15. Excess iron inhibits osteoblast metabolism.
Yamasaki K; Hagiwara H
Toxicol Lett; 2009 Dec; 191(2-3):211-5. PubMed ID: 19735707
[TBL] [Abstract][Full Text] [Related]
16. The L-, N-, and T-type triple calcium channel blocker benidipine acts as an antagonist of mineralocorticoid receptor, a member of nuclear receptor family.
Kosaka H; Hirayama K; Yoda N; Sasaki K; Kitayama T; Kusaka H; Matsubara M
Eur J Pharmacol; 2010 Jun; 635(1-3):49-55. PubMed ID: 20307534
[TBL] [Abstract][Full Text] [Related]
17. Volume regulatory decrease in UMR-106.01 cells is mediated by specific alpha1 subunits of L-type calcium channels.
Kizer N; Harter L; Hruska K; Alvarez U; Duncan R
Cell Biochem Biophys; 1999; 31(1):65-79. PubMed ID: 10505668
[TBL] [Abstract][Full Text] [Related]
18. Five different profiles of dihydropyridines in blocking T-type Ca(2+) channel subtypes (Ca(v)3.1 (alpha(1G)), Ca(v)3.2 (alpha(1H)), and Ca(v)3.3 (alpha(1I))) expressed in Xenopus oocytes.
Furukawa T; Nukada T; Namiki Y; Miyashita Y; Hatsuno K; Ueno Y; Yamakawa T; Isshiki T
Eur J Pharmacol; 2009 Jun; 613(1-3):100-7. PubMed ID: 19401195
[TBL] [Abstract][Full Text] [Related]
19. Mechanism underlying the block of human Cav3.2 T-type Ca2+ channels by benidipine, a dihydropyridine Ca2+ channel blocker.
Inayoshi A; Sugimoto Y; Funahashi J; Takahashi S; Matsubara M; Kusaka H
Life Sci; 2011 May; 88(19-20):898-907. PubMed ID: 21466810
[TBL] [Abstract][Full Text] [Related]
20. Twisted gastrulation and chordin inhibit differentiation and mineralization in MC3T3-E1 osteoblast-like cells.
Petryk A; Shimmi O; Jia X; Carlson AE; Tervonen L; Jarcho MP; O'connor MB; Gopalakrishnan R
Bone; 2005 Apr; 36(4):617-26. PubMed ID: 15780974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
